Hydrix (ASX:HYD) has announced that its wholly owned subsidiary, Hydrix Services, has entered a contract with SynCardia Systems, a subsidiary of Picard Medical, to commence the initial development phase of SynCardia's next-generation fully implantable total artificial heart, known as the Emperor.
Valued at approximately $2.5 million, the project is expected to be completed within the 2026 calendar year and represents the first phase of a broader, multi-stage, multiyear program that will progress through engineering, verification, and regulatory milestones.
The collaboration will focus on a ground-up systems architecture encompassing electromechanical actuation, embedded software, energy management, and safety-critical redundancy.
Patrick N.J. Schnegelsberg, CEO of SynCardia Systems, said, "Hydrix's expertise and demonstrated track record in advancing complex cardiovascular technologies will support our shared objective of developing transformative solutions for patients with advanced heart failure."